TABLE 4.
Pat # | Pretreatment | BLV year 1 | BLV year 2 | Virological response at HVPG (∆log HDV‐RNA) | PEG‐IFN at 2nd HVPG |
---|---|---|---|---|---|
HVPG (mmHg) | HVPG (mmHg) | HVPG (mmHg) | |||
P 2 | 19 | — | 15 (−21%) | −5.17 | Yes |
P 4 | 17 | 13 (−24%) | — | −3.00 | Yes |
P 9 | 6 | — | 7 (+17%) | RNA undetectable | No |
P 11 | 18 | 21 (+17%) | −2.08 a | Yes | |
P 13 | 10 | 10 (±0%) | −1.37 | No |
P11 had intermittent, significant alcohol abuse.
Green background: clinically relevant decrease in liver stiffness or HVPG; Yellow background: insignificant change in liver sitffness or HVPG; Red background: clinically increase in liver stiffness or HVPG.